GENMAB A/S (GMAB)
Clinical trial NCT07166094 updates: 1. completion date: 2029-02-01 → 2029-11-01 2. primary completion date: 2028-11-01 → 2029-08-01 3. enrollment: 544 → 660 participants
Clinical trial NCT07166094 updates: 1. completion date: 2029-02-01 → 2029-11-01 2. primary completion date: 2028-11-01 → 2029-08-01 3. enrollment: 544 → 660 participants
📉 **NEGATIVE** • Medium confidence analysis (67%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical